T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors - PubMed (original) (raw)
T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors
S Y Lee et al. J Exp Med. 1996.
Abstract
CD30 is a member of the tumor necrosis factor superfamily and a surface marker for Hodgkin's disease. Normal activated T cells and several virally transformed T or B cell lines also show CD30 expression. The interaction of CD30 with its ligand induces cell death or proliferation, depending on the cell type. In this report we characterize the signals mediated by the intracellular domain of CD30 and show that, in combination with signal(s) transduced by the T cell receptor, the multimerization of CD30 cytoplasmic domain induces Fas(CD95)-independent cell death in T cell hybridomas. Deletion analysis shows that the COOH-terminal 66 amino acids of CD30 are required to induce cell death. Using the yeast two-hybrid system, we have identified that the same region of CD30 interacts with tumor necrosis factor receptor-associated factor (TRAF)1 and TRAF2. These results indicate that TRAF1 and/or TRAF2 play an important role in cell death in addition to their previously identified roles in cell proliferation.
Similar articles
- CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
Lee SY, Lee SY, Kandala G, Liou ML, Liou HC, Choi Y. Lee SY, et al. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9699-703. doi: 10.1073/pnas.93.18.9699. Proc Natl Acad Sci U S A. 1996. PMID: 8790394 Free PMC article. - CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2.
Tsitsikov EN, Wright DA, Geha RS. Tsitsikov EN, et al. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1390-5. doi: 10.1073/pnas.94.4.1390. Proc Natl Acad Sci U S A. 1997. PMID: 9037063 Free PMC article. - Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.
Duckett CS, Gedrich RW, Gilfillan MC, Thompson CB. Duckett CS, et al. Mol Cell Biol. 1997 Mar;17(3):1535-42. doi: 10.1128/MCB.17.3.1535. Mol Cell Biol. 1997. PMID: 9032281 Free PMC article. - Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family.
Schneider C, Hübinger G. Schneider C, et al. Leuk Lymphoma. 2002 Jul;43(7):1355-66. doi: 10.1080/10428190290033288. Leuk Lymphoma. 2002. PMID: 12389614 Review. - CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J, Herrmann F. Gruss H-J, et al. Leuk Lymphoma. 1996 Feb;20(5-6):397-409. doi: 10.3109/10428199609052421. Leuk Lymphoma. 1996. PMID: 8833395 Review.
Cited by
- A novel anti-membrane CD30 single-chain variable fragment discovered from the human phage library: A potential targeted immunotherapy.
Chanpong T, Seesuay W, Chiangjong W, Jiramornimit P, Preedagasamzin S, Atjanasuppat K, Jittorntrum B, Prasongtanakij S, Tawinwung S, Pukiat S, Saisawang C, Borwornpinyo S, Sa-Ngiamsuntorn K, Chaichumpa W, Hongeng S, Anurathapan U. Chanpong T, et al. PLoS One. 2023 Apr 20;18(4):e0284708. doi: 10.1371/journal.pone.0284708. eCollection 2023. PLoS One. 2023. PMID: 37079526 Free PMC article. - TNF Receptor Associated Factor 2 (TRAF2) Signaling in Cancer.
Siegmund D, Wagner J, Wajant H. Siegmund D, et al. Cancers (Basel). 2022 Aug 22;14(16):4055. doi: 10.3390/cancers14164055. Cancers (Basel). 2022. PMID: 36011046 Free PMC article. Review. - Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
Tsuyama N, Sakamoto K, Sakata S, Dobashi A, Takeuchi K. Tsuyama N, et al. J Clin Exp Hematop. 2017;57(3):120-142. doi: 10.3960/jslrt.17023. J Clin Exp Hematop. 2017. PMID: 29279550 Free PMC article. Review. - Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.
Bohra C, Sokol L, Dalia S. Bohra C, et al. Cancer Control. 2017 Oct-Dec;24(4):1073274817729901. doi: 10.1177/1073274817729901. Cancer Control. 2017. PMID: 28975841 Free PMC article. Review. - Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
Hasanali ZS, Saroya BS, Stuart A, Shimko S, Evans J, Vinod Shah M, Sharma K, Leshchenko VV, Parekh S, Loughran TP Jr, Epner EM. Hasanali ZS, et al. Sci Transl Med. 2015 Jun 24;7(293):293ra102. doi: 10.1126/scitranslmed.aaa5079. Sci Transl Med. 2015. PMID: 26109102 Free PMC article. Clinical Trial.
References
- Nature. 1982 Sep 2;299(5878):65-7 - PubMed
- Cell. 1995 May 19;81(4):513-23 - PubMed
- Cell. 1985 Feb;40(2):237-46 - PubMed
- Biochemistry. 1984 Dec 18;23(26):6544-9 - PubMed
- Blood. 1985 Oct;66(4):848-58 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous